DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Tullemans BME, Heemskerk JWM, Kuijpers MJE.
Acquired platelet antagonism: off-target antiplatelet effects of malignancy treatment with tyrosine kinase inhibitors.
J Thromb Haemost 2018;
16 (09) 1686-1699
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.